Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 174

1.

MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage.

Kouidhi S, Rouissi K, Khedhiri S, Ouerhani S, Cherif M, Benammar-Elgaaied A.

Asian Pac J Cancer Prev. 2011;12(9):2227-32.

2.

Genetic susceptibility of methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C, and G1793A polymorphisms with risk for bladder transitional cell carcinoma in men.

Safarinejad MR, Shafiei N, Safarinejad S.

Med Oncol. 2011 Dec;28 Suppl 1:S398-412. doi: 10.1007/s12032-010-9723-9. Epub 2010 Oct 29.

PMID:
21046286
3.

Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study.

Lin J, Spitz MR, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, Pillow PC, Grossman HB, Wu X.

Carcinogenesis. 2004 Sep;25(9):1639-47. Epub 2004 Apr 29.

4.

Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk: a meta-analysis from 41 studies with 16,480 cases and 22,388 controls.

Qi X, Ma X, Yang X, Fan L, Zhang Y, Zhang F, Chen L, Zhou Y, Jiang J.

Breast Cancer Res Treat. 2010 Sep;123(2):499-506. doi: 10.1007/s10549-010-0773-7. Epub 2010 Feb 5.

PMID:
20135343
5.

MTHFR C677T and A1298C polymorphisms and cervical carcinoma susceptibility: meta-analyses based on 4,421 individuals.

Zhuo WL, Zhang L, Ling JJ, Zhu Y, Chen ZT.

Mol Biol Rep. 2012 Sep;39(9):8723-32. doi: 10.1007/s11033-012-1732-7. Epub 2012 Jun 19.

PMID:
22711309
6.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population.

Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, D'ugo D, Magistrelli P, Villari P, Van Duijn CM, Ricciardi G.

Biomarkers. 2007 Nov-Dec;12(6):635-44.

PMID:
17972183
7.

MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis.

You W, Li Z, Jing C, Qian-Wei X, Yu-Ping Z, Weng-Guang L, Hua-Lei L.

DNA Cell Biol. 2013 May;32(5):260-7. doi: 10.1089/dna.2012.1931. Epub 2013 Apr 11. Review.

PMID:
23578207
8.

Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer.

Cao HX, Gao CM, Takezaki T, Wu JZ, Ding JH, Liu YT, Li SP, Su P, Cao J, Hamajima N, Tajima K.

Asian Pac J Cancer Prev. 2008 Apr-Jun;9(2):203-8.

9.

MTHFR polymorphisms and ovarian cancer risk: a meta-analysis.

Liu L, Liao SG, Wang YJ.

Mol Biol Rep. 2012 Nov;39(11):9863-8. Epub 2012 Jul 19.

PMID:
22810649
10.

Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population.

Ouerhani S, Oliveira E, Marrakchi R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, Amorim A, El Gaaied AB, Prata MJ.

Cancer Genet Cytogenet. 2007 Jul 1;176(1):48-53.

PMID:
17574963
11.

Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis.

Wang M, Zhu H, Fu G, Wang M, Zhang Z, Lu Q, Wang S, Zhang Z.

Clin Exp Med. 2009 Mar;9(1):9-19. doi: 10.1007/s10238-008-0013-1. Epub 2008 Sep 25.

PMID:
18815869
12.

Quantitative assessment of the effect of MTHFR polymorphisms on the risk of lung carcinoma.

Zhang Y, Chen GQ, Ji Y, Huang B, Shen WS, Deng LC, Xi L, Cao XM.

Mol Biol Rep. 2012 May;39(5):6203-11. doi: 10.1007/s11033-011-1439-1. Epub 2012 Jan 4.

PMID:
22215214
13.

MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.

Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.

Breast Cancer Res Treat. 2010 Sep;123(2):549-55. doi: 10.1007/s10549-010-0783-5. Epub 2010 Feb 9.

PMID:
20143151
14.

Relationships among MTHFR a1298c gene polymorphisms and methylation status of Dact1 gene in transitional cell carcinomas.

Cheng H, Lu M, Mao LJ, Wang JQ, Li W, Wen RM, Chen JC.

Asian Pac J Cancer Prev. 2012;13(10):5069-74.

15.

MTHFR gene polymorphisms in bladder cancer in the Turkish population.

Izmirli M, Inandiklioglu N, Abat D, Alptekin D, Demirhan O, Tansug Z, Bayazit Y.

Asian Pac J Cancer Prev. 2011;12(7):1833-5.

16.

The polymorphism of methylenetetrahydrofolate reductase C677T but not A1298C contributes to gastric cancer.

Lv L, Wang P, Sun B, Chen G.

Tumour Biol. 2014 Jan;35(1):227-37. doi: 10.1007/s13277-013-1028-0. Epub 2013 Jul 30.

PMID:
23897558
17.

Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.

Chou YC, Wu MH, Yu JC, Lee MS, Yang T, Shih HL, Wu TY, Sun CA.

Carcinogenesis. 2006 Nov;27(11):2295-300. Epub 2006 Jun 15.

18.

Quantitative assessment of the associations between MTHFR C677T and A1298C polymorphisms and risk of fractures: a meta-analysis.

Bai R, Liu W, Zhao A, Zhao Z, Jiang D.

Mol Biol Rep. 2013 Mar;40(3):2419-30. doi: 10.1007/s11033-012-2322-4. Epub 2012 Dec 11.

PMID:
23229495
19.

Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer.

Zhao P, Lin F, Li Z, Lin B, Lin J, Luo R.

Asian Pac J Cancer Prev. 2011;12(8):2019-23.

20.

Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C.

Sazci A, Ergul E, Tuncer N, Akpinar G, Kara I.

Brain Res Bull. 2006 Dec 11;71(1-3):45-50. Epub 2006 Aug 15.

PMID:
17113927
Items per page

Supplemental Content

Write to the Help Desk